Search Results - "Rueda Ramos, A"

Experience with a simplified format of decision making tool adjuvant! Online in breast cancer patients by Baena Cañada, J M, Ramírez Daffós, P, Díaz Díaz, V, Estalella Mendoza, S, Díaz Gómez, L, González Calvo, E, Arriola Arellano, E, Gómez Reina, M J, Contreras Ibáñez, J A, Rueda Ramos, A

“…Adjuvant! Online estimates 10-year recurrence and mortality outcomes for breast cancer patients and predicts the effect of each type of treatment. Our purpose…”
Get full text

9135 Erlotinib as maintenance therapy after platinun-based chemotherapy in advanced non-small-cell lung cancer (NSCLC): a phase II trial by Cobo-Dols, M, Barneto-Aranda, I, Bernabé-Caro, R, Valdivia, J, Fernandez-Canton, I, Cruzdela, L, Rueda-Ramos, A, Villatoro, R, Beló, J

Get full text

Experiencia con un formato simplificado de la herramienta de ayuda en la toma de decisiones Adjuvant! Online en pacientes con cáncer de mama by Baena Cañada, J.M, Ramírez Daffós, P, Díaz Díaz, V, Estalella Mendoza, S, Díaz Gómez, L, González Calvo, E, Arriola Arellano, E, Gómez Reina, M.J, Contreras Ibáñez, J.A, Rueda Ramos, A

“…Resumen Fundamento Adjuvant! Online calcula el riesgo de recidiva y muerte a 10 años y proporciona estimaciones del beneficio del tratamiento adyuvante en…”
Get full text

Spanish Women'S Perceptions of Mammography Screening by Baena-Cañada, J.M., Rosado-Varela, P., Cortés-Carmona, C., Estalella-Mendoza, S., Ramírez-Daffós, P., Arriola-Arellano, E., Gómez-Reina, M.J., Contreras-Ibáñez, J.A., Rueda-Ramos, A., Nieto-Vera, J., Benítez-Rodríguez, E.

Get full text

Using an Informed Consent in Mammography Screening: Final Result of a Randomized Trial by Varela, P. Rosado, Cañada, J.M. Baena, Daffós, P. Ramirez, Álvarez, I. Expósito, Guerrero, M. González, Rodriguez, E. Benítez, Arellano, E. Arriola, Reina, M.J. Gómez, Carmona, C. Cortés, Mendoza, S. Estalella, Ibáñez, J.A. Contreras, Ramos, A. Rueda

Get full text

1362PUSING AN INFORMED CONSENT IN MAMMOGRAPHY SCREENING: FINAL RESULT OF A RANDOMIZED TRIAL by Varela, P. Rosado, Cañada, J.M. Baena, Daffós, P. Ramirez, Álvarez, I. Expósito, Guerrero, M. González, Rodriguez, E. Benítez, Arellano, E. Arriola, Reina, M.J. Gómez, Carmona, C. Cortés, Mendoza, S. Estalella, Ibáñez, J.A. Contreras, Ramos, A. Rueda

“…Abstract Aim: In Spain women do not make an informed choice on participation in breast cancer screening. The aim of the study was to evaluate the influence of…”
Get full text

1364PSPANISH WOMEN'S PERCEPTIONS OF MAMMOGRAPHY SCREENING by Baena-Cañada, J.M., Rosado-Varela, P., Cortés-Carmona, C., Estalella-Mendoza, S., Ramírez-Daffós, P., Arriola-Arellano, E., Gómez-Reina, M.J., Contreras-Ibáñez, J.A., Rueda-Ramos, A., Nieto-Vera, J., Benítez-Rodríguez, E.

“…Abstract Aim: Participants in breast cancer screening programmes may benefit from early detection but may also be exposed to the risks of overdiagnosis and…”
Get full text

Carcinoma no microcítico de pulmón. Supervivencia y factores pronósticos del tratamiento radioterápico by Jaén Olasolo, J., Alonso Redondo, E., León Jiménez, A., Rueda Ramos, A.

“…Analizar los resultados de la radioterapia en el carcinoma no microcítico de pulmón y las características clí-nicas y terapéuticas que pueden influir en ellos…”
Get full text

Evaluation of response to neoadjuvant chemotherapy using breast scintigraphy in breast cancer by Baena-Cañada, José M, Partida-Palma, Francisca, Palomo-González, María J, Benítez, Encarnación, Rueda-Ramos, Antonio, García-Curiel, Antonio

“…We sought to evaluate the usefulness of Tc-99m-sestamibi breast scintigraphy in predicting neoadjuvant chemotherapy response in patients with breast cancer. In…”
Get more information

Carcinoma no microcítico de pulmón. Supervivencia y factores pronósticos del tratamiento radioterápico by Jaén Olasolo, J, Alonso Redondo, E, León Jiménez, A, Rueda Ramos, A

Get full text

Non-small cell lung cancer. Survival after radiotherapy and prognostic factors by Jaén Olasolo, J, Alonso Redondo, E, León Jiménez, A, Rueda Ramos, A

“…To analyze the results of radiotherapy for non-small cell lung cancer and identify the clinical and therapeutic variables that might influence prognosis. In a…”
Get full text